By Colin Kellaher Guardant Health shares fell sharply Wednesday after the precision-oncology company was hit with a patent-infringement verdict topping $80.
By Ian Walker Novacyt shares rose 21% in London after the company said that its DPYD genotyping assay, which identifies cancer patients that are at risk of.